Issues in the treatment of bipolar disorder (Q35212737)

7 August 2017

1 reference

title

Issues in the treatment of bipolar disorder (English)

1 reference

7 August 2017

1 reference

1

Siegfried Kasper

0 references

language of work or name

English

0 references

publication date

1 August 2003

1 reference

European Neuropsychopharmacology

7 August 2017

1 reference

7 August 2017

13 Suppl 2

1 reference

7 August 2017

S37-42

1 reference

The emerging epidemiology of hypomania and bipolar II disorder

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Historical perspectives and natural history of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Some common issues in the use of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Efficacy and safety of novel antipsychotics: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Olanzapine: a review of its use in the treatment of bipolar I disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Strategies to Reduce Misdiagnosis of Bipolar Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Perspectives on the use of anticonvulsants in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Lithium for maintenance treatment of mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Clinical factors associated with treatment noncompliance in euthymic bipolar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Clinical Factors in Lithium Carbonate Prophylaxis Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Reliability and relationship of various ages of onset criteria for major affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Epidemiology of affective disorders in Florence. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Relapse and impairment in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Antidepressant-induced mania in bipolar patients: identification of risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Suicide after discharge from psychiatric inpatient care

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

The long-term natural history of the weekly symptomatic status of bipolar I disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

A review of randomized, controlled clinical trials in acute mania

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Outcome in the pharmacologic treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Anticonvulsants in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Course of the Manic-Depressive Cycle and Changes Caused by Treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Treatment non-adherence in affective disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Gabapentin treatment for bipolar disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Validity of rapid cycling as a course specifier for bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Affective disorders and depression as measured by the Diagnostic Interview Schedule and the Beck Depression Inventory in an unselected adult population.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Systematic overview of lithium treatment in acute mania

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

The combat of non-compliance during prophylactic lithium treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Health care utilization and costs among patients treated for bipolar disorder in an insured population.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Recent advances in the treatment of bipolar mania, depression, mixed states, and rapid cycling.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Lifetime prevalence of specific mental disorders among people born in Iceland in 1931.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Suicidality among patients with mixed and manic bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

A meta-analysis of the use of typical antipsychotic agents in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900076-2

7 January 2021

10.1016/S0924-977X(03)00076-2

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12957718